Slc2a13 | solute carrier family 2 (facilitated glucose transporter), member 13
Physiological systems
20 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Behavior/neurological
18 No significant impact
4 Not tested
Data collections
Gene metrics:2Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
impaired glucose tolerance | 1 supporting dataset | Slc2a13em1(IMPC)Mbp | homozygote | Early adult | 6.37x10-5 | ||
increased freezing behavior | 1 supporting dataset | Slc2a13em1(IMPC)Mbp | homozygote | Early adult | 4.09x10-5 |
| | | | | | | | | |
External links
No external links available for Slc2a13.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Slc2a13em1(IMPC)Mbp | Exon Deletion | | mouse |
Slc2a13tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Slc2a13tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |